Bio Rad实验室(BIO)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

BIO Bio Rad实验室

盘前交易 11-05 08:27:47 EST

368.92

+0.50

+0.14%

盘前368.92

+0.000.00%

08:02 EST

最高372.10	最低365.13	成交量20.21万
今开367.06	昨收368.42	日振幅1.89%
总市值103.29亿	流通市值71.56亿	总股本2,800万
成交额7,451万	换手率1.04%	流通股本1,940万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"BIO","market":"US","secType":"STK","nameCN":"Bio Rad实验室","latestPrice":368.92,"timestamp":1730754000000,"preClose":368.42,"halted":0,"volume":202085,"hourTrading":{"tag":"盘前","latestPrice":368.92,"preClose":368.92,"latestTime":"08:02 EST","volume":10,"amount":3671.6800000000003,"timestamp":1730811755666},"delay":0,"floatShares":19398507,"shares":27996765,"eps":-27.407322,"marketStatus":"盘前交易","marketStatusCode":1,"change":0.5,"latestTime":"11-05 08:27:47 EST","open":367.06,"high":372.1,"low":365.13,"amount":74512146.6531,"amplitude":0.018919,"askPrice":416.66,"askSize":10,"bidPrice":364.86,"bidSize":6,"shortable":3,"etf":0,"ttmEps":-27.407322,"exchange":"NYSE","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1730817000000},"adr":0,"adjPreClose":368.92,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":368.92,"preClose":368.92,"latestTime":"08:02 EST","volume":10,"amount":3671.6800000000003,"timestamp":1730811755666},"postHourTrading":{"tag":"盘后","latestPrice":368.92,"preClose":368.92,"latestTime":"16:25 EST","volume":6276,"amount":2315323.15,"timestamp":1730755549482},"volumeRatio":0.7700136485104953,"impliedVol":0.3847,"impliedVolPercentile":0.4542},"requestUrl":"/m/hq/s/BIO","defaultTab":"news","newsList":[{"id":"2480606903","title":"Bio Rad实验室2024财年第三财季实现净利润6.53亿美元，同比增加516.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480606903","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480606903?lang=zh_cn&edition=full","pubTime":"2024-11-04 00:01","pubTimestamp":1730649679,"startTime":"0","endTime":"0","summary":"11月4日，Bio Rad实验室公布财报，公告显示公司2024财年第三财季净利润为6.53亿美元，同比增加516.04%；其中营业收入为6.50亿美元，同比增加2.85%，每股基本收益为23.37美元。从资产负债表来看，Bio Rad实验室总负债31.16亿美元，其中短期债务44.10百万美元，资产负债比为3.41，流动比率为6.14。机构评级：截至2024年11月4日，当前有6家机构对Bio Rad实验室目标价做出预测，其中目标均价为397.33美元，其中最低目标价为315.00美元，最高目标价为469.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104000231a211d3d7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104000231a211d3d7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BIO","BIO.B"],"gpt_icon":0},{"id":"2479942039","title":"美国研究综述-Altair 工程公司、布林克国际公司、梅塔公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2479942039","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479942039?lang=zh_cn&edition=full","pubTime":"2024-10-31 22:41","pubTimestamp":1730385704,"startTime":"0","endTime":"0","summary":"    路透10月31日 - 华尔街证券分析师周四调整了对Altair Engineering、Brinker International和Meta等几家美国上市公司的评级和目标价。要闻 * Altair Engineering Inc   ：尼德姆将其评级从 \"买入 \"下调至 \"持有 * Blackbaud Inc   ：贝雅将其评级从 \"跑赢大盘 \"下调至 \"中性\"。* Brinker International Inc   ：摩根大通将其评级从 \"增持 \"下调至 \"中性\"。* Meta   ：贝尔德将目标价从605美元上调至630美元 以下是路透周四报导的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BKNG","ALTR","CHRW","ABBV","META","CAT","LU1854104046.USD","ALHC","LU1169589451.USD","CDW","ALL","ALRS","BRO","ANSS","LU2264538146.SGD","AVT","CWH","ALMS","BLKB","AVDL","ALKT","AXTA","ATI","AUR","BK4140","ATEC","BG","BIO","IE00BZ199S13.USD","AEIS","BMRC","IE00BFXG0V08.USD","ARCC","BK4141","BL","IE0009354923.USD","ATNI","BIIB","LU0061474960.USD","TECH","ADP","AX","EAT","IE00BMPRXN33.USD","IE00BMPRXR70.SGD","ARVN","BPMC"],"gpt_icon":1},{"id":"1197166163","title":"异动解读 | Bio Rad实验室股价大涨7.73% 分析师看好长期前景","url":"https://stock-news.laohu8.com/highlight/detail?id=1197166163","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1197166163?lang=zh_cn&edition=full","pubTime":"2024-10-31 22:03","pubTimestamp":1730383419,"startTime":"0","endTime":"0","summary":"10月31日,Bio Rad实验室股价盘中大涨7.73%,报收于349.76美元/股,引发市场广泛关注。据报道,公司最新一季度营收和净利润数据表现亮眼,且机构分析师对其长期增长前景持乐观看法。消息面上,Bio Rad上一季度实现营业收入6.38亿美元,环比增长5.2%,超出预期。多家机构调高了对Bio Rad的评级和目标价。分析人士认为,Bio Rad具备全面的产品线和创新管线,有望持续受益于生命科学和医疗健康市场的快速增长。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["BIO"],"gpt_icon":0},{"id":"2479482080","title":"Bio Rad实验室盘中异动 早盘股价大涨5.80%报349.76美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479482080","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479482080?lang=zh_cn&edition=full","pubTime":"2024-10-31 21:35","pubTimestamp":1730381706,"startTime":"0","endTime":"0","summary":"北京时间2024年10月31日21时35分，Bio Rad实验室股票出现异动，股价大幅拉升5.80%。截至发稿，该股报349.76美元/股，成交量5288股，换手率0.02%，振幅0.00%。Bio Rad实验室股票所在的医疗器械行业中，整体跌幅为0.35%。Bio Rad实验室公司简介：伯乐生命医学产品有限公司总部位于美国加利福尼亚州的Hercules，为临床诊断和生命科学市场开发、制造和销售产品和解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103121350695bd9c86&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103121350695bd9c86&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1169590202.USD","BIO.B","BK4585","BK4588","LU1169589451.USD","BIO","BK4121"],"gpt_icon":0},{"id":"2479722217","title":"美国研究综述-全州保险公司、布林克国际公司、梅塔公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2479722217","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479722217?lang=zh_cn&edition=full","pubTime":"2024-10-31 15:30","pubTimestamp":1730359839,"startTime":"0","endTime":"0","summary":"    路透10月31日 - 华尔街证券分析师周四调整了对几家美国上市公司的评级和目标价，其中包括 Allstate、Brinker International 和 Meta。要闻 * 全州公司  ：摩根大通将目标价从207美元上调至217美元             * Blackbaud Inc   ：贝雅将其评级从 \"跑赢大盘 \"下调至 \"中性\"。* Meta   ：贝尔德将目标价从605美元上调至630美元 以下是路透周四报导的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COIN","BABA","EQT","CRK","ITCI","PDD","GRAB","ABBV","CLX","HLI","MSTR","FND","EAT","SOFI","CRWD","FSBC","GEHC","IE00B19Z6F94.USD","IRTC","LU0882574055.USD","DASH","ALKT","NVDA","LU1064131342.USD","ALRS","ALL","BIDU","BLKB","BMRC","ATI","RIVN","IE00BYQQ9H92.USD","CTSH","ADP","BIO","SKY","LU2023250504.SGD","LU0106261372.USD","HUBG","AFRM","IE00B19Z4B17.USD","RIOT","CDW","EBAY","CAT","BRO","JKHY","LU1059921491.USD","LU2125910336.SGD","KHC","LU0354030438.USD","LU0708994859.HKD","HTLF","ILMN","ECL","BK4130","CFLT","DHI","BKNG","BIIB"],"gpt_icon":1},{"id":"2479762165","title":"诊断部门销售强劲，Bio-Rad 实验室季度利润超出预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2479762165","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479762165?lang=zh_cn&edition=full","pubTime":"2024-10-31 06:07","pubTimestamp":1730326064,"startTime":"0","endTime":"0","summary":"Bio-Rad 还为医院和医生生产和销售血液及其他诊断测试工具。生物技术行业支出的减少，以及作为药物开发关键地区的中国需求的低迷，打击了 Bio-Rad 公司最近几个季度的利润。Bio-Rad 第三季度净销售总额为 6.497 亿美元，高于分析师预计的 6.282 亿美元。经调整后，Bio-Rad公司在截至9月30日的第三季度实现每股利润2.01美元，高于分析师预计的1.16美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4566","LU1169590202.USD","LU1057294990.SGD","LU1623119135.USD","LU1923621640.USD","LU1983299246.USD","LU0011850046.USD","BK4533","LU1169589451.USD","LU0266013472.USD","BIO","IE00BJJMRZ35.SGD","LU2041044095.USD","IE0002141913.USD","IE00B19Z8W00.USD","IE00B2B36J28.USD","LU1023059063.AUD","BK4534","LU0957791311.USD","BK4535","IE00BFTCPJ56.SGD","IE0034235188.USD","GB00BDT5M118.USD","LU1923622291.USD","LU0096362180.USD","LU0640476718.USD","IE0009355771.USD","LU1670628061.USD","IE00BKPKM429.USD","LU0234572021.USD","LU1712237335.SGD","BK4588","TMO","LU2092937221.SGD","LU0061474960.USD","LU0528227936.USD","IE00B19Z9505.USD","LU1988902786.USD","LU1291159041.SGD","LU2089984988.USD","LU0557290698.USD","IE00B19Z8X17.USD","LU1064131342.USD","IE00BJT1NW94.SGD","LU1720051108.HKD","LU0342679015.USD","LU1280957306.USD","LU1633808545.USD","LU1923622614.USD","LU1720051017.SGD"],"gpt_icon":0},{"id":"2476120621","title":"Bio Rad实验室盘中异动 早盘快速拉升6.12%报349.97美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2476120621","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476120621?lang=zh_cn&edition=full","pubTime":"2024-10-17 21:33","pubTimestamp":1729171981,"startTime":"0","endTime":"0","summary":"北京时间2024年10月17日21时33分，Bio Rad实验室股票出现异动，股价急速拉升6.12%。截至发稿，该股报349.97美元/股，成交量1.3565万股，换手率0.05%，振幅0.00%。Bio Rad实验室股票所在的医疗器械行业中，整体涨幅为0.31%。Bio Rad实验室公司简介：伯乐生命医学产品有限公司总部位于美国加利福尼亚州的Hercules，为临床诊断和生命科学市场开发、制造和销售产品和解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101721330298e3cfee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101721330298e3cfee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1169590202.USD","BIO.B","BK4585","BK4588","LU1169589451.USD","BIO","BK4121"],"gpt_icon":0},{"id":"2470621447","title":"Bio Rad实验室盘中异动 股价大涨5.06%报331.51美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2470621447","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470621447?lang=zh_cn&edition=full","pubTime":"2024-09-27 04:00","pubTimestamp":1727380805,"startTime":"0","endTime":"0","summary":"北京时间2024年09月27日04时00分，Bio Rad实验室股票出现波动，股价急速上涨5.06%。截至发稿，该股报331.51美元/股，成交量15.9521万股，换手率0.57%，振幅3.51%。Bio Rad实验室股票所在的医疗器械行业中，整体涨幅为0.65%。Bio Rad实验室公司简介：伯乐生命医学产品有限公司总部位于美国加利福尼亚州的Hercules，为临床诊断和生命科学市场开发、制造和销售产品和解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092704000598e392d8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092704000598e392d8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1169590202.USD","BIO.B","BK4585","BK4588","LU1169589451.USD","BIO","BK4121"],"gpt_icon":0},{"id":"2469605498","title":"Bio Rad实验室盘中异动 临近收盘大幅下跌5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2469605498","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469605498?lang=zh_cn&edition=full","pubTime":"2024-09-21 03:51","pubTimestamp":1726861918,"startTime":"0","endTime":"0","summary":"北京时间2024年09月21日03时51分，Bio Rad实验室股票出现异动，股价急速下挫5.08%。截至发稿，该股报327.09美元/股，成交量33.7813万股，换手率1.21%，振幅4.41%。Bio Rad实验室股票所在的医疗器械行业中，整体跌幅为0.26%。Bio Rad实验室公司简介：伯乐生命医学产品有限公司总部位于美国加利福尼亚州的Hercules，为临床诊断和生命科学市场开发、制造和销售产品和解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092103515898e384f1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092103515898e384f1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1169589451.USD","BK4121","LU1169590202.USD","BIO.B","BK4588","BK4585","BIO"],"gpt_icon":0},{"id":"2468629167","title":"BUZZ-Palantir、戴尔在纳入标普500指数前下滑","url":"https://stock-news.laohu8.com/highlight/detail?id=2468629167","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468629167?lang=zh_cn&edition=full","pubTime":"2024-09-20 22:03","pubTimestamp":1726840987,"startTime":"0","endTime":"0","summary":"    9月20日 - ** 戴尔科技  和数据分析公司Palantir Technologies  分别下跌约1.7%，财产保险公司伊利赔偿  下跌0.2%。** 根据9月6日的公告，在9月23日开市前进行指数再平衡时，这些公司将被纳入基准标普500指数  。** 美国航空集团  、Etsy  和Bio-Rad实验室  被纳入基准指数。** 美国航空持平，Etsy下跌2.2%，Bio-Rad下跌3.7","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4500","BK4515","ESmain","BK4121","LU1861558580.USD","SPXU","SSO","ETSY","DELL","OEF","BK4220","BK4122","BK4170","BK4585","SH","BK4504","LU1169590202.USD","SPY","BK4559",".SPX","BK4534","BK4588","BK4532","PLTR","BK4023","BK4107","AAL","BIO","BK4543","BK4535","BK4008","LU1861559042.SGD","LU1169589451.USD","SDS","BK4581","OEX","BK4550","IVV","ERIE","BK4547","LU0267386448.USD"],"gpt_icon":1},{"id":"2466162126","title":"BUZZ-伊利赔偿公司因被纳入标准普尔 500 指数而获益","url":"https://stock-news.laohu8.com/highlight/detail?id=2466162126","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2466162126?lang=zh_cn&edition=full","pubTime":"2024-09-09 20:44","pubTimestamp":1725885894,"startTime":"0","endTime":"0","summary":"** 加入标普500指数通常对股市是个好消息，因为基金经理和追踪标普500指数的交易所交易基金会买入股票以匹配相关指数。** 标准普尔道琼斯工业平均指数称，ERIE取代了标普500指数中的Bio-Rad Laboratories   ，后者追踪的是大市值公司的表现。** 截至上一交易日收盘，ERIE 年累计涨幅约为 51%；BIO 同期涨幅约为 2","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4107",".SPX","BK4121","ERIE","LU1169589451.USD","BK4588","BUZZ","BK4585","LU1169590202.USD","BIO"],"gpt_icon":0},{"id":"2466641491","title":"戴尔(DELL)和Palantir(PLTR)将纳入标普500指数成分股","url":"https://stock-news.laohu8.com/highlight/detail?id=2466641491","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2466641491?lang=zh_cn&edition=full","pubTime":"2024-09-09 20:28","pubTimestamp":1725884922,"startTime":"0","endTime":"0","summary":"金吾财讯 | 标普全球 公布，个人电脑及服务器生产商戴尔科技、美国情报部门外判资料分析商Palantir、美国保险行业领导者Erie Indemnity Co．将加入成为标普500指数成分股。据悉，加入标普500指数成分股股份须在最近四个季度累计录得盈利，以及于最新季度录得盈利，戴尔科技自2019年每季均录盈利，Palantir在2020年上市，自2022年第四季以来每季均录盈利。两股目前市值分别为逾720亿及逾670亿美元，标普500指数成分股市值中位数为335亿美元。","market":"us","thumbnail":"https://static.szfiu.com/news/20210625/NzU1OThlNmM0MjcyNDY3NGZjMzI1Mzg0Mzg5MzM5.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210625/NzU1OThlNmM0MjcyNDY3NGZjMzI1Mzg0Mzg5MzM5.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"279701","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4535","BK4121","BK4500","BK4534","BK4588","ERIE","BK4550","OEF","PLTR","BK4532","OEX","BK4220","BK4170","UPRO",".SPX","LU1861559042.SGD","LU0267386448.USD","BK4559","BIO","BK4008","BK4543","BK4581","ESmain","SPXU","SDS","DELL","BK4107","SH","BK4504","BK4547","LU1861558580.USD","ETSY","LU1169589451.USD","SSO","LU1169590202.USD","SPY","BK4515","IVV","BK4585","BK4122","BK4023"],"gpt_icon":1},{"id":"2465262194","title":"戴尔、Palantir 和伊利赔偿公司将加入标普 500 指数","url":"https://stock-news.laohu8.com/highlight/detail?id=2465262194","media":"Reuters","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2465262194?lang=zh_cn&edition=full","pubTime":"2024-09-07 06:10","pubTimestamp":1725660643,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    路透9月6日 - 标准普尔道琼斯指数公司周五称，服务器制造商戴尔科技  、数据分析公司Palantir Technologies  和财产与意外保险公司伊利赔偿公司  将在9月23日开盘前加入基准标普500指数  。 Palantir 的股价在延时交易中上涨了近 8%，戴尔和伊利的股价分别上涨了 6% 和 3%。 这三家公司将取代美国航空集团  、在线市场Etsy  和诊断公司Bio-Rad Laboratories  进入该指数。 美国航空公司的股价下跌了0.7%，而Bio-Rad Laboratories和Etsy的股价下跌了约1%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DELL","BK4170","ERIE","BK4535","BK4585","PLTR","BK4515",".SPX","BK4122","LU0267386448.USD","BK4543","LU1861559042.SGD","BK4008","BK4121","ETSY","BK4220","BK4547","BK4023","BIO","BK4588","LU1169590202.USD","BK4532","LU1861558580.USD","BK4500","BK4107","LU1169589451.USD"],"gpt_icon":1},{"id":"1176774403","title":"一周美股牛股 | 百思买全周飙14%；英特尔着手扭转困局，全周涨7%；伯克希尔加入万亿美元俱乐部","url":"https://stock-news.laohu8.com/highlight/detail?id=1176774403","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1176774403?lang=zh_cn&edition=full","pubTime":"2024-09-02 10:46","pubTimestamp":1725245203,"startTime":"0","endTime":"0","summary":"百思买去年更新了其会员计划，并在重组计划中裁减了员工，旨在应对店内需求减弱的情况下提升利润率。摩根士丹利维持对 $GE Vernova Inc.$ 的增持评级，认为最新叶片问题风险较小上周一，摩根士丹利重申了对GE Vernova的增持评级，并设定了220美元的目标价。伯克希尔加入了其他六家主要来自科技行业的万亿美元公司：苹果、英伟达、微软、谷歌母公司Alphabet、亚马逊和脸书母公司Meta平台。","market":"us","thumbnail":"https://community-static.tradeup.com/news/95b2b20b201e3eada64180b0770a622f","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/95b2b20b201e3eada64180b0770a622f"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"一周美股牛股 | 百思买全周飙14%；英特尔着手扭转困局，全周涨7%；伯克希尔加入万亿美元俱乐部","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIO","INTC","BBY","GEV","BRK.B","PODD","RMD","JKHY","CPAY","NSC"],"gpt_icon":1},{"id":"2462078171","title":"Bio-Rad Laboratories(BIO.US)获富国银行首次覆盖","url":"https://stock-news.laohu8.com/highlight/detail?id=2462078171","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462078171?lang=zh_cn&edition=full","pubTime":"2024-08-28 13:22","pubTimestamp":1724822562,"startTime":"0","endTime":"0","summary":"Bio-Rad Laboratories(BIO.US)获 富国银行 首次覆盖，给予持股观望评级,目标价340.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082813371795cb2033&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082813371795cb2033&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0417517546.SGD","IE00B7SZLL34.SGD","LU0162691827.USD","LU0052756011.USD","BIO.B","LU1069347547.HKD","LU1074936037.SGD","LU1169590202.USD","BK4207","LU0477156953.USD","LU1035773651.USD","LU2236285917.USD","LU1791807156.HKD","LU0072461881.USD","BK4504","LU0175139822.USD","LU0742534661.SGD","LU1267930227.SGD","LU0980610538.SGD","BK4588","IE0002270589.USD","LU0106831901.USD","LU0251142724.SGD","LU0256863811.USD","LU0130102774.USD","LU0128525689.USD","LU0310800965.SGD","LU0648001328.SGD","IE00B19Z3B42.SGD","BK4559","IE00B19Z3581.USD","LU0048573561.USD","LU0149725797.USD","LU0208291251.USD","BIO","LU0971096721.USD","LU0640476718.USD","LU0289960550.SGD","LU0683600562.USD","LU0130517989.USD","BK4585","WFC","LU0251131958.USD","LU1201861249.SGD","LU1169589451.USD","LU0320765489.SGD","BK4501","LU1668664300.SGD","BK4121","LU0070302665.USD","LU1280957306.USD"],"gpt_icon":0},{"id":"2459494296","title":"BIO-Key International Inc 报告截至 6 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2459494296","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459494296?lang=zh_cn&edition=full","pubTime":"2024-08-15 14:00","pubTimestamp":1723701641,"startTime":"0","endTime":"0","summary":"   * BIO-Key International Inc   报告，截至6月底的季度调整后每股亏损100美分，高于去年同期的每股收益2.88美元。分析师对该季度的唯一预测是每股亏损 54 美分。* 收入同比下降 40.8%，为 114 万美元；分析师预期为 195 万美元。* BIO-Key International Inc 股价本季度下跌了 14.9%，今年迄今为止下跌了 53.5%。8月15日 - 预测变化   * 在过去 30 天内，覆盖该公司的分析师没有对盈利预期进行修正。华尔街对 BIO-Key International Inc 的 12 个月目标价中位数为 5.00 美元。本摘要由 LSEG 8 月 15 日上午 06:00  的调制解调器器生成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIO","LU1169589451.USD","BK4588","BK4121","BKYI","LU1169590202.USD","BK4097","BK4585"],"gpt_icon":0},{"id":"2459176965","title":"BIO-Key International Inc    预计每股亏损 54 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2459176965","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459176965?lang=zh_cn&edition=full","pubTime":"2024-08-13 06:24","pubTimestamp":1723501451,"startTime":"0","endTime":"0","summary":"   * BIO-Key International Inc    预计在8月14日公布的截至2024年6月30日的财报中将显示季度收入增长。* LSEG 的分析师平均预计 BIO-Key International Inc 每股亏损 54 美分。* 电子设备和零部件同行的平均一致建议也是 \"买入\"。* 华尔街对 BIO-Key International Inc 的 12 个月目标价中位数为 5.00 美元，高于其最新收盘价 1.37 美元。8月12日 - 本摘要于北京时间 8 月 12 日 22:24 机器生成。除非另有说明，否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BKYI","BIO"],"gpt_icon":0},{"id":"2458272515","title":"Bio Rad实验室2024财年第二财季实现净利润-21.65亿美元，同比减少86.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2458272515","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458272515?lang=zh_cn&edition=full","pubTime":"2024-08-10 00:23","pubTimestamp":1723220582,"startTime":"0","endTime":"0","summary":"8月10日，Bio Rad实验室公布财报，公告显示公司2024财年第二财季净利润为-21.65亿美元，同比减少86.32%；其中营业收入为6.38亿美元，同比减少6.31%，每股基本收益为-76.26美元。从资产负债表来看，Bio Rad实验室总负债29.10亿美元，其中短期债务42.00百万美元，资产负债比为3.33，流动比率为6.28。机构评级：截至2024年8月10日，当前有6家机构对Bio Rad实验室目标价做出预测，其中目标均价为355.83美元，其中最低目标价为315.00美元，最高目标价为401.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408100023109f1e149d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408100023109f1e149d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BIO","BIO.B"],"gpt_icon":0},{"id":"2458569897","title":"BIO-Key International Inc    预计每股亏损 54 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2458569897","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458569897?lang=zh_cn&edition=full","pubTime":"2024-08-09 19:27","pubTimestamp":1723202831,"startTime":"0","endTime":"0","summary":"   * BIO-Key International Inc    预计在8月12日公布截至2024年6月30日的业绩时，季度收入将有所增长()    * 根据LSEG的数据，一位分析师预计这家总部位于新泽西州霍姆德尔的公司的营收将从去年同期的193万美元增至195万美元，增幅为1.1%。* LSEG 的分析师平均预计 BIO-Key International Inc 每股亏损 54 美分。* 华尔街对 BIO-Key International Inc 的 12 个月目标价中位数为 5.00 美元，高于其最新收盘价 1.37 美元。8月9日 - 本摘要于北京时间 8 月 9 日 11:27 机器生成。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIO","BKYI"],"gpt_icon":0},{"id":"2457269210","title":"KALA BIO 公司公布截至 6 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2457269210","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457269210?lang=zh_cn&edition=full","pubTime":"2024-08-06 22:20","pubTimestamp":1722954025,"startTime":"0","endTime":"0","summary":"   * KALA BIO Inc   报告了截至6月底的季度调整后每股亏损3.16美元，高于去年同期的每股亏损4.36美元。两位分析师对该季度的平均预期是每股亏损 4.40 美元。华尔街预期为每股亏损 4.58 美元至 4.23 美元。* KALA BIO 公司公布的季度每股收益为亏损 3.16 美元。* 该公司当季亏损 958 万美元。* KALA BIO Inc 本季度股价下跌了 16.1%，今年迄今为止下跌了 15.0%。8月6日 - 预测变化   * 在过去三个月里，分析师的平均盈利预期下降了约 54%。华尔街对 KALA BIO Inc 的 12 个月目标价中位数为 16.50 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4588","BK4007","BK4121","BIO","KALA","BK4585"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.bio-rad.com","stockEarnings":[{"period":"1week","weight":0.1227},{"period":"1month","weight":0.0734},{"period":"3month","weight":0.1284},{"period":"6month","weight":0.3752},{"period":"1year","weight":0.2815},{"period":"ytd","weight":0.1426}],"compareEarnings":[{"period":"1week","weight":-0.019},{"period":"1month","weight":-0.0055},{"period":"3month","weight":0.0913},{"period":"6month","weight":0.1017},{"period":"1year","weight":0.3108},{"period":"ytd","weight":0.1988}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Bio-Rad Laboratories, Inc.成立于1952年并于1957年成立为公司。它早期致力于研究和生产用于生物化学，制药和其他生命科学研究运用的专用化学品。在其首次技术分离套件和生命科学研究材料都有所发展的情况下，它进入了临床诊断学领域。通过内部的研发努力和决策，它向不同的市场进行了扩张。现在，Bio-Rad为生命科学研究，医疗保健，分析化学和其他市场生产提供了一系列的产品。","yearOnYearQuotes":[{"month":1,"riseRate":0.522727,"avgChangeRate":0.026111},{"month":2,"riseRate":0.590909,"avgChangeRate":0.01002},{"month":3,"riseRate":0.636364,"avgChangeRate":0.041103},{"month":4,"riseRate":0.622222,"avgChangeRate":0.043048},{"month":5,"riseRate":0.6,"avgChangeRate":0.017548},{"month":6,"riseRate":0.511111,"avgChangeRate":0.002824},{"month":7,"riseRate":0.577778,"avgChangeRate":0.008353},{"month":8,"riseRate":0.4,"avgChangeRate":-0.00089},{"month":9,"riseRate":0.422222,"avgChangeRate":-0.012005},{"month":10,"riseRate":0.466667,"avgChangeRate":-0.005097},{"month":11,"riseRate":0.644444,"avgChangeRate":0.028157},{"month":12,"riseRate":0.659091,"avgChangeRate":0.024433}],"exchange":"NYSE","name":"Bio Rad实验室","nameEN":"Bio-Rad Laboratories"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Bio Rad实验室(BIO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Bio Rad实验室(BIO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Bio Rad实验室,BIO,Bio Rad实验室股票,Bio Rad实验室股票老虎,Bio Rad实验室股票老虎国际,Bio Rad实验室行情,Bio Rad实验室股票行情,Bio Rad实验室股价,Bio Rad实验室股市,Bio Rad实验室股票价格,Bio Rad实验室股票交易,Bio Rad实验室股票购买,Bio Rad实验室股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Bio Rad实验室(BIO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Bio Rad实验室(BIO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}